An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering substances of unknown origin.
Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Reaction and Content Elimination
Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
Within moments of joining one group, a seller shared contact information, where most purchases take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Product Information and Pricing
Within these groups, messages display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has already seen patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to possibly serious health risks”.
